online pharmacy, prescription drugs online



Drugs online research references











  • Stimulatory and inhibitory effects of ethanol on hippocampal acetylcholine release.
  • Lithocholyltaurine interacts with cholinergic receptors on dispersed chief cells from guinea pig stomach.
  • Synthesis and pharmacological characterization of O-alkynyloximes of tropinone and N-methylpiperidinone as muscarinic agonists.
  • The effects of muscarinic cholinergic receptor blockade in the rat anterior cingulate and Prelimbic/Infralimbic cortices on spatial working memory.
  • Effects of antidepressant treatment on inhibitory avoidance behavior and amygdaloid beta-adrenoceptors in rats.
  • Role of 5-HT4 receptors in the mouse passive avoidance test.
  • The effect of hypothalamic peptide YY on hippocampal acetylcholine release in vivo: implications for limbic function in binge-eating behavior.
  • Assessment of autonomic nervous activity during gastrointestinal endoscopy: analysis of blood pressure variability by tonometry.
  • Characterization of an atypical muscarinic cholinoceptor mediating contraction of the guinea-pig isolated uterus.
  • Role of the cholinergic systems of the dorsal and ventral striatum of the rat brain in controlling learned movements.
  • Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.
  • Effect of anisodine on acute forebrain ischemia-reperfusion damage in rats.
  • The specific dopamine uptake inhibitor GBR 12783 improves learning of inhibitory avoidance and increases hippocampal acetylcholine release.
  • Involvement of nicotinergic mechanisms in thyrotropin-releasing hormone-induced neurologic recovery after concussive head injury in the mouse.
  • Effects of ginkgo biloba extract on impairment of learning induced by cerebral ischemia in mice.
  • Antagonist of nitric oxide synthesis inhibits nerve-mediated relaxation of isolated strips of rumen and reticulum.
  • Comparison of Seven Commonly Used Agents for Prophylaxis of Seasickness.
  • Antagonist profile and molecular dynamic simulation of a Drosophila melanogaster muscarinic acetylcholine receptor.
  • An automated learning and memory model in mice: pharmacological and behavioral evaluation of an autoshaped response.
  • Effects of psychoactive drugs on temporal discrimination in rats.
  • Autonomic nervous influence of the female guinea-pig urinary bladder during the oestrus cycle.
  • State dependent and/or direct memory retrieval by morphine in mice.
  • Haloperidol, raclopride, and eticlopride induce microcatalepsy during operant performance in rats, but clozapine and SCH 23390 do not.
  • Memory facilitation and stimulation of endogenous nerve growth factor synthesis by the acetylcholine releaser PG-9.
  • Distribution of muscarinic receptor subtypes in rat small intestine.
  • The effects of d-amphetamine and scopolamine on drinking induced by a multiple schedule.
  • Cloning and expression of a G protein-linked acetylcholine receptor from Caenorhabditis elegans.
  • Combined therapy affects outcomes differentially after mild traumatic brain injury and secondary forebrain ischemia in rats.
  • Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment.
  • Glucose minimally attenuates scopolamine-but not morphine-induced deficits on a water maze alternation task.
  • Assessment of gastric cancer: value of breathhold technique and two-phase spiral CT.
  • Effects of chlordiazepoxide and scopolamine, but not aging, on the detection and identification of conditional visual stimuli.
  • Drug effects on discrimination performance at two levels of stimulus control.
  • Ontogeny of muscarinic cholinergic supersensitivity in the Flinders Sensitive Line rat.
  • Synthesis and muscarinic activity of novel aniline derivatives with a 1-azabicyclo3.3.0octane moiety.
  • Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms.
  • The blockage of ponto-geniculo-occipital waves in the cat lateral geniculate nucleus by nicotinic antagonists.
  • Septal modulation of the population spike in the fascia dentata produced by perforant path stimulation in the rat.
  • The effect of soman on potassium evoked 3H-acetylcholine release in the isolated rat bronchi.
  • Hippocampal evoked potentials and EEG changes during classical conditioning in the rat.
  • Transcallosal evoked potentials: behavior-dependent modulation by muscarinic and serotonergic receptors.
  • Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
  • Effects of SUN 8399, a potent and selective 5-HT1A agonist, on conflict behavior and ambulatory activity in mice: comparison with those of buspirone, tandospirone and diazepam.
  • Generalization of the discriminative stimulus properties of phencyclidine to other drugs in the pigeon using color tracking under second order schedules.
  • Comparative pharmacological profile of muscarinic agonists in the isolated ileum, the pithed rat, and the mouse charcoal meal transit test.
  • Differential sensitivity of phosphoinositide and cyclic GMP responses to short-term regulation by a muscarinic agonist in mouse neuroblastoma cells. Correlation with down-regulation of cell surface receptors.
  • Development of tolerance to amnesic effects of chlordiazepoxide in relation to GABAergic and cholinergic neuronal systems.
  • Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study.
  • Lethal effects of reserpine plus physostigmine and neostigmine in mice.
  • In vitro down-regulation predicts agonist efficacy at central muscarinic cholinergic receptors.
  • Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection.
  • Cholinergic blockade in prefrontal cortex and hippocampus disrupts short-term memory in rats.
  • Respiratory effects of premedication during enflurane N2O anaesthesia in children.
  • A study of three preoperative sedative combinations.
  • The mechanisms of memory disorders at the stages in its acquisition and fixation
  • Effect of anticholinergic preanesthetic medicaments on the requirements of halothane for anesthesia in the cat.
  • Acquisition of a lever press behavior by mice in a water reinforcement situation
  • Identification of the primary muscarinic autoreceptor subtype in rat striatum as m2 through a correlation of in vivo microdialysis and in vitro receptor binding data.
  • Modulation of memory processing by neuropeptide Y.
  • A brief brain ischemia produces morphological damage of hippocampal CA1 pyramidal cells without affecting the sensitivities of psychoactive drugs in two types of discrete avoidance tasks in Mongolian gerbils.
  • Effect of naloxone and prolonged preganglionic stimulation on noncholinergic transmission in the superior cervical ganglion of the cat.
  • Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
  • Discriminative stimulus properties of muscarinic agonists.
  • Discriminative stimulus properties of NIK-247 and tetrahydroaminoacridine, centrally active cholinesterase inhibitors, in rats.
  • Adrenoceptor blocking properties of atropine-like agents anisodamine and anisodine on brain and cardiovascular tissues of rats.
  • Further evidence for the dissociation of locomotor activity and head dipping in rats.
  • Competitive inhibition by procaine of carbachol-induced stimulus-secretion coupling in rat pancreatic acini.
  • Distinct kinetic binding properties of N-3H-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
  • Colic medication and apparent life-threatening events.
  • Construction and application of atropine flow-through sensor in flow injection analysis
  • Effects of DM-9384, a pyrrolidone derivative, on alcohol- and chlordiazepoxide-induced amnesia in mice.
  • Functionalized congener approach to muscarinic antagonists: analogues of pirenzepine.
  • Dopamine--acetylcholine "balance" in nucleus accumbens and corpus striatum and its effect on hypothalamic self-stimulation.
  • Quantitative assessment of quinolinic acid-induced striatal toxicity in rats using radioligand binding assays.
  • Application of a radioreceptor assay in a pharmacokinetic study of oxitropium bromide in healthy volunteers after single i.v., oral and inhalation doses.
  • Effects of (R)-alpha-methylhistamine and scopolamine on spatial learning in the rat assessed using a water maze.
  • TRH and its analog (DN-1417). Effects on central dopaminergic system-dependent behaviors in rats and mice
  • Exploration in immature rats: effects of drugs.
  • Studies on desglycinamide arginine vasopressin and scopolamine in a modified/lever-touch autoshaping model of learning/memory in rats.
  • Drug-induced rotation in rats without lesions: behavioral and neurochemical indices of a normal asymmetry in nigro-striatal function.
  • Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics.
  • A role for acetylcholine receptors in the fusion of chick myoblasts.
  • Subclasses of muscarinic receptors in isolated gastric mucosal cells: receptor characterization and parietal cell function.
  • Muscarinic acetylcholine receptors on an identified motor neurone in the cockroach, Periplaneta americana.
  • Activation of muscarinic receptors induces a long-lasting enhancement of Purkinje cell responses to glutamate.
  • Reduction of muscarinic receptor density and of guanine nucleotide-stimulated phosphoinositide hydrolysis in human SH-SY5Y neuroblastoma cells following long-term treatment with 12-O-tetradecanoylphorbol 13-acetate or mezerein.
  • Effects of muscarinic receptor agonists and antagonists on rat brain serotonergic activity.
  • Effects of baclofen on dopamine metabolism and interaction with neuroleptic effects.
  • Effects of muscarinic receptor agonists and antagonists on alpha 2-adrenoceptors in rat brain.
  • Effects of muscarinic receptor agonists and anticholinesterase drugs on high voltage spindles and slow waves.
  • Evidence for GABA-BZ receptor modulation in short-term memory passive avoidance task paradigm in mice.
  • Cholinergic regulation of arterial pressure by the C1 area of the rostral ventrolateral medulla.
  • The role of adrenergic receptors in the initiation of vomiting and its gastrointestinal motor correlates.
  • Synthesis, release and receptor binding of acetylcholine in the C1 area of the rostral ventrolateral medulla: contributions in regulating arterial pressure.
  • Muscarinic cholinergic receptor subtype on frog esophageal peptic cells: binding and secretion studies.
  • Subtypes of muscarinic receptors in cultured explants of the hippocampus of the rat.
  • Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
  • Muscarinic cholinergic receptors in human foetal brain: characterization and ontogeny of 3Hquinuclidinyl benzilate binding sites in frontal cortex.
  • Carbachol-induced down-regulation of receptors for pancreatic secretagogues.
  • Muscarinic cholinergic receptor binding: in vivo depiction using single photon emission computed tomography and radioiodinated quinuclidinyl benzilate.
  • Muscarinic cholinergic receptor binding in rat brain at 15 days following traumatic brain injury.
  • Transient impairment of recognition memory following ibotenic-acid lesions of the basal forebrain in macaques.
  • Effects of serotoninergic receptor antagonists and their combination with scopolamine on memory.
  • The effects of muscarinic receptor blockers on the turnover rate of acetylcholine in various regions of the rat brain.
  • Concurrent changes in regional cholinergic parameters and nest odor preference in the early postnatal rat after lead exposure.
  • Cholecystokinin-induced regulation of muscarinic receptor on dispersed pancreatic acini.
  • Cisplatin increases the release of 5-hydroxytryptamine (5-HT) from the isolated vascularly perfused small intestine of the guinea-pig: involvement of 5-HT3 receptors.
  • A toggle-floor box: the reliability of crossings in the evaluation of drug-induced locomotor changes in mice.
  • Antagonists to cholinergic receptors increase the frequency of binuclear V79 Chinese hamster cells. A mechanism for induction of aneuploidy.
  • Hyperthermia induced by the dopamine D1 receptor agonist SK&F38393 in combination with the dopamine D2 receptor agonist talipexole in the rat.
  • Possible involvement of central cholinergic system in ameliorating effects of indeloxazine, a cerebral activator, on disturbance of learning behavior in rats.
  • Midlatency auditory evoked responses: differential effects of a cholinergic agonist and antagonist.
  • Alveolitis after operative removal of third molars in the mandible.
  • Effect of physostigmine on relative acetylcholine output induced by systemic treatment with scopolamine in in vivo microdialysis of rat frontal cortex.
  • Structure-activity requirements for hypotension and alpha-adrenergic receptor blockade by analogues of atropine.
  • Impairment of contractile response to carbachol and muscarinic receptor coupling in gastric antral smooth muscle cells isolated from diabetic streptozotocin-treated rats and db/db mice.
  • Drug effects on response-duration differentiation. II: Selective effects of antidepressant drugs.
  • Scopolamine affects response-to-change test involving 20-min retention interval after locomotor exploration in rats.
  • Cholinergic gating of response to auditory stimuli in rat hippocampus.
  • Radial maze as a tool for assessing the effect of drugs on the working memory of rats.
  • Arteriolar smooth muscle responses are modulated by an intramural diffusion barrier.
  • Effects of dopamine D-1 and D-2 antagonists on decision making by rats: no reversal of neuroleptic-induced attenuation by scopolamine.
  • Henbane (Hyoscyamus reticulatus) poisoning in children in the Negev
  • Facilitation of memory retrieval by pre-test morphine and its state dependency in the step-through type passive avoidance learning test in mice.
  • Effects of extract from Rhapontcum carthamoides (Willd) Iljin (Leuzea) on learning and memory in rats.
  • Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine.
  • Control of the neuronal rhythmic bursts in the septal pacemaker of theta-rhythm: effects of anaesthetic and anticholinergic drugs.
  • Urinary bladder function in rats with hereditary diabetes insipidus; a cystometrical and in vitro evaluation.
  • M1 muscarinic acetylcholine receptor in cultured rat neostriatum regulates phosphoinositide hydrolysis.
  • Scopolamine disrupts visual reversal without affecting the first discrimination.
  • M3 muscarinic acetylcholine receptor coupling to PLC in rat exorbital lacrimal acinar cells.
  • A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants.
  • Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons.
  • Effects of physostigmine, scopolamine, and mecamylamine on the sleeping time induced by ketamine in the rat.
  • Effects of treatment with scopolamine and naloxone, singly and in combination, on amygdala kindling.
  • Reversal of scopolamine-induced alterations of choline transport across the blood-brain barrier by the nootropics piracetam and pramiracetam.
  • Strength of scopolamine-induced amnesia as a function of time between training and testing.
  • Analysis and stability of atropine sulfate and scopolamine hydrobromide. 3: Studies on the stability of tropane alkaloids; 80: contribution to problems in the use of plastic containers for liquid pharmaceuticals
  • Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze.
  • Interaction among scopolamine, conditioned stimulus modality, genotype, and either-way avoidance behavior of rats.
  • Nicotine reverses scopolamine-induced impairment of performance in passive avoidance task in rats through its action on the dopaminergic neuronal system.
  • Pharmacokinetics of scopolamine during caesarean section: relationship between serum concentration and effect.
  • Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.
  • Salivary glucose clearance, dry mouth and pH changes in dental plaque in man.
  • Hyperbaric oxygen and scopolamine.
  • Inhibitory effect of scopolamine on recent memory of mice
  • Effects of transdermal scopolamine on heart rate variability in normal subjects.
  • Specific 3H-N-methyl scopolamine binding without cholinergic function in cultured adult skin fibroblasts.
  • Efficacy comparison of scopolamine (SCP) and diazepam (DZ) against soman-induced lethality in guinea pigs.
  • Differential effects of scopolamine on working and reference memory depend upon level of training.
  • Effect of idebenone on scopolamine-induced impairment of short-term memory in rats
  • Differential effects of scopolamine and mecamylamine on working and reference memory in the rat.
  • A monoclonal antibody to scopolamine and its use for competitive enzyme-linked immunosorbent assay.
  • Age-dependent effects of scopolamine on avoidance, locomotor activity, and rearing.
  • Problems of test choice and data analysis in behavioral teratology: the case of prenatal benzodiazepines.
  • D-cycloserine attenuates scopolamine-induced learning and memory deficits in rats.
  • Muscarinic receptors and second-messenger responses of neurons in primary culture.
  • Odorant stimulation of secretory and neural processes in the salamander olfactory mucosa.
  • Physostigmine reversal of sedation in parturients.
  • Thermic response of selective muscarinic agonists and antagonists in rat.
  • Increased anticholinergic sensitivity following closed skull impact and controlled cortical impact traumatic brain injury in the rat.
  • Effects of scopolamine on serotonin in the spinal cord and atria of morphine-dependent rats
  • Cholinergic modulation of separation distress in the domestic chick.
  • Role of cholinergic and serotoninergic processes in modulating the activity of the negative reinforcement system
  • Cholinergic regulation of sexual behavior in female hamsters.
  • Sulphotransferase-dependent dehydration of atropine and scopolamine in guinea pig.
  • Computer-assisted shock-reinforced Y-maze training: a method for studying spatial alternation behaviour.
  • Scopolamine affects short-term memory but not inferior temporal neurons.
  • Habituation and motion sickness.
  • Susceptibility to motion sickness and the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy.
  • Two ligands may bind simultaneously to the muscarine receptor.
  • Adrenergic receptors on smooth muscle cells isolated from human penile corpus cavernosum.
  • Regulation of muscarinic acetylcholine receptors in cultured guinea pig pancreatic acini.
  • Is the effect of somatostatin on muscarinic receptors selective to M1 type?
  • Comparison of various spasmolytic drugs on guinea-pig isolated common bile duct.
  • Cholinergic mediation of spatial memory in the preweanling rat: application of the radial arm maze paradigm.
  • Effects of scopolamine and d-amphetamine on locomotor activity before and after shock: a diallel analysis in mice.
  • Hippocampal interictal spikes induced by kindling: relations to behavior and EEG.
  • Behavioral microanalysis of spatial delayed alternation performance: rehearsal through overt behavior, and effects of scopolamine and chlordiazepoxide.
  • Muscarinic receptor subtype selectivity of novel heterocyclic QNB analogues.
  • Muscarinic receptor subtype specificity of 5'-(isobutylthio)-adenosine (SIBA) and its analogs.
  • Endoscopic manometry of the sphincter of Oddi in dogs. Pharmacological effects of anticholinergic and selective antimuscarinic agents.
  • Pharmacology of theta phase shift in the hippocampal CA1 region of freely moving rats.
  • Treatment with oral estrone sulphate in the female climacteric. II. Hormonal aspects.
  • Features of memory on novel situation and avoidance response: evidence from comparisons between open-field behavior and step-through task.
  • Possible involvement of the septo-hippocampal cholinergic and raphe-hippocampal serotonergic activations in the penile erection induced by fenfluramine in rats.
  • Differential attenuation of some effects of haloperidol in rats given scopolamine.
  • Effects of anticholinergic drugs on rabbit efferent phrenic discharges.
  • Prevention of muscarinic acetylcholine receptor down-regulation by chloroquine: antilysosomal or antimuscarinic mechanisms.
  • Cholinergic mechanisms in startle and prepulse inhibition: effects of the false cholinergic precursor N-aminodeanol.
  • Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats.
  • Muscarinic receptor stimulation increases inositol-phospholipid metabolism and inhibits cyclic AMP accumulation in PC12 cells.
  • Motor responses of autoimmune NZB/B1NJ and C57BL/6Nnia mice to arecoline and nicotine.
  • Role of stimulus locale on strain differences in active avoidance after scopolamine of D-amphetamine treatment.
  • Fos immunoreactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in the rat.
  • Synthesis and structure-activity studies of a series of spirooxazolidine-2,4-diones: 4-oxa analogues of the muscarinic agonist 2-ethyl-8-methyl-2,8-diazaspiro4.5decane-1,3-dione.
  • Experimental models for studying the avoidance response in mice and the anti-amnesic effect of prolyl endopeptidase inhibitors
  • Muscarinic stimulation of submucosal glands in swine trachea.
  • Effect of anticholinergic drugs alone and in combination with nembutal on burst theta-neurons of the rabbit septum
  • Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum.
  • Characterization of the subtype of muscarinic receptor coupled to the stimulation of phosphoinositide hydrolysis in 132-1N1 human astrocytoma cells.
  • A cholinergic input to the substantia nigra pars compacta increases striatal dopamine metabolism measured by in vivo voltammetry.
  • Cholinergic agonists suppress play fighting in juvenile rats.
  • Circadian variation in susceptibility to the ambulation-increasing effect of scopolamine in mice.
  • Motion sickness in cats: a symptom rating scale used in laboratory and flight tests.
  • Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
  • Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (IV): Effects on experimental memory impairment in mice and rats.
  • Potentiation of odor by taste and odor aversions in rats are regulated by cholinergic activity of dorsal hippocampus.
  • Effects of cholecystokinin tetra and octa peptides on locomotor activity in mice.
  • Effects of anticholinergic drugs on DRL performance of rhesus monkeys.
  • Head-upright tilt-table testing: a useful tool in the evaluation and management of recurrent vertigo of unknown origin associated with near-syncope or syncope.
  • Reversal by tetrahydroaminoacridine of scopolamine-induced memory and performance deficits in rats.
  • The rat ventromedial thalamic nucleus and motor control: role of N-methyl-D-aspartate-mediated excitation, GABAergic inhibition, and muscarinic transmission.
  • Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
  • Cholinergic mechanisms in the reticular control of transmission in the cat lateral geniculate nucleus.
  • Nonuniform expression of the dopamine-positive effect in different central m-cholinergic blockaders
  • Neurolept anaesthesia for the renal transplant operation.
  • Pharmacologic analysis of the postictal immobility syndrome in the rat.
  • The effect of atropine on the activation of 5-hydroxytryptamine3 channels in rat nodose ganglion neurons.
  • Scopolamine injected into the rat amygdala impairs working memory in the double Y-maze.
  • Cortical ablation and drug-induced changes in striatal ascorbic acid oxidation and behavior in the rat.
  • Effects of transient cerebral ischemia in gerbils on working memory performance in the delayed nonmatching to position task using a T-maze.
  • Criminological aspects of the clarification of alkaloid intoxications
  • Acetylcholine receptors in the human retina.
  • Cholinergic involvement in the action of formetanate on operant behavior in rats.
  • Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
  • A novel anticholinesterase THB013: biochemical and behavioural studies.
  • Effects of YM-14673, a new thyrotropin-releasing hormone analogue, on impaired learning of passive avoidance in mice.
  • Effect of thyrotropin-releasing hormone on pentobarbitone-induced sleep in rats: continuous treatment with a sustained release injectable formulation.
  • Effects of apomorphine, TL-99 and 3-PPP on yawning in rats.
  • Cholinergic modulation of tonic immobility in the rabbit (Oryctolagus cuniculus).
  • Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies.
  • Effects of psychoactive drugs on conditioned avoidance response in Mongolian gerbils (Meriones unguiculatus): comparison with Wistar rats and dd mice.
  • A system for assessing toxicity of chemicals by continuous monitoring of homecage behaviors.
  • The effects of pre-exposure to scopolamine on subsequent drug state discrimination.
  • Prospective study utilizing transdermal scopolamine in detrusor instability.
  • Actions of acetylcholine in the guinea-pig and cat medial and lateral geniculate nuclei, in vitro.
  • Validation of a radial maze test for assessing learning and memory in rats.
  • Neuroeffector mechanisms of the defense reaction in the rat.
  • Effect of JTP-2942, a novel thyrotropin-releasing hormone analogue, on pentobarbital-induced anesthesia in rats.
  • Effects of DX-9386, a traditional Chinese preparation, on passive and active avoidance performances in mice.
  • Cholinergic synaptic transmission between proprioceptive afferents and a hind leg motor neuron in the locust.
  • Possible involvement of a transmitter different from norepinephrine in the residual responses to nerve stimulation of the cat nictitating membrane after pretreatment with reserpine.
  • Effects of pesticides and drugs on working memory in rats: continuous delayed response.
  • Chronic scopolamine treatment and brain cholinergic function.
  • Effects of scopolamine treatment on long-term behavioral deficits following concussive brain injury to the rat.
  • Partition behavior of tropane alkaloids between organic solvents and water
  • Transdermal scopolamine as treatment of bradyarrhythmias.
  • The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus.
  • Cellular mechanisms underlying cholinergic and noradrenergic modulation of neuronal firing mode in the cat and guinea pig dorsal lateral geniculate nucleus.
  • Effects of scopolamine and unilateral lesions of the basal forebrain on T-maze spatial discrimination and alternation in rats.
  • Scopolamine induces up-regulation of nicotinic receptors in intact brain but not in nucleus basalis lesioned rats.
  • Genetic and ontogenetic variations in locomotor activity following treatment with scopolamine or d-amphetamine.
  • Effect of atropine on vascular adrenergic neuroeffector transmission.
  • Effects of noradrenergic DSP4 lesion on the effectiveness of pilocarpine in reversing scopolamine-induced amnesia.
  • The variation of acetylcholine release from myenteric neurones with stimulation frequency and train length. Role of presynaptic muscarine receptors.
  • Hemodynamic effects of vasopressin compared with angiotensin II in conscious rats.
  • Electrophysiological and behavioral reactivity to photic stimuli following septal lesions and pharmacological treatments in rats.
  • Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
  • Modulation of cortical in vivo acetylcholine release by the basal nuclear complex: role of the pontomesencephalic tegmental area.
  • Time gradient for post-test vulnerability to scopolamine-induced amnesia following the initial acquisition session of a spatial reference memory task in mice.
  • Reduction of salivary flow with transdermal scopolamine: a four-year experience.
  • Anatomical specificity within rat striatum for the dopaminergic modulation of DRL responding and activity.
  • Scopolamine interactions with D1 and D2 antagonists on radial-arm maze performance in rats.
  • Scopolamine impairs both working and reference memory in rats: a replication and extension.
  • Anomalous binding of 3HN-methylscopolamine to rat brain muscarinic receptors.
  • Studies on the mechanism of wet dog shakes produced by carbachol in rats.
  • Choline inhibits acetylcholine release via presynaptic muscarine receptors.
  • The role of dopamine in behavioral supersensitivity to muscarinic antagonists following cholinesterase inhibition.
  • Effects of the benzodiazepine receptor agonist midazolam and antagonist flumazenil on 5-hydroxytryptamine release from guinea-pig intestine in vitro. Indirect support for a "natural" benzodiazepine-like substance in the intestine.
  • An involvement of acetylcholine in object discrimination learning and memory in the marmoset.
  • Involvement of central beta-adrenoceptors in the regulation of yawning responses.
  • Bidirectional effects of beta-carbolines and benzodiazepines on cognitive processes.
  • Antagonist discrimination between subtypes of tachykinin receptors in the guinea-pig ileum.
  • The interaction of acetylcholinergic and serotonergic neural systems on performance in a continuous non-matching to sample task.
  • A possible relationship between folic acid neurotoxicity and cholinergic receptors in the pyriform cortex and amygdala.
  • Age-related scopolamine effects on social and individual behaviour in rats.
  • 3H-methyl scopolamine binding to dispersed pancreatic acini.
  • A study of 3H-PK 11,195 binding to "peripheral-type" benzodiazepine receptors on human lymphocytes. Evidence of decreased binding in hepatic encephalopathy.
  • 3HN-Methylscopolamine binding to muscarinic receptors in intact adult rat brain cell aggregates.
  • Contraction and 3HQNB binding in collagenase isolated fundic smooth muscle cells.
  • Endothelin-1 causes a biphasic response in systemic vasculature and increases myocardial contractility in conscious rabbits.
  • Failure of muscarinic blockade to antagonize analepsis induced by thyrotropin-releasing hormone and MK-771 in the rat.
  • Anticholinergic drugs, blood-brain-barrier and tonic immobility in chickens.
  • Mental dysfunction and the blockade of muscarinic receptors in the brains of the normal elderly.
  • A method of direct chemical brain stimulation in behavioral studies using microiontophoresis.
  • Lack of specific binding of bradykinin and D-Arg Hyp3, Thi5, D-Tic, Oic8 bradykinin in membranes from rat heart.
  • Prenatal benzodiazepine effects in mice: postnatal behavioral development, response to drug challenges, and adult discrimination learning.
  • Muscarinic binding sites on bovine pulmonary arterial endothelial cells in culture.
  • The effect of M1 muscarinic blockade on behavior and physiological responses following traumatic brain injury in the rat.
  • Desipramine induces yawning behaviour in rats.
  • Effect of thyroid status on beta-adrenoreceptors and muscarinic receptors in the rat lung.
  • Dentate gyrus and olfactory bulb responses to olfactory and noxious stimulation in urethane anaesthetized rats.
  • The role of muscarinic acetylcholine receptors in ocular dominance plasticity.
  • Effect of mazindol administration on (3H)-N-methylscopolamine binding to rat cerebral cortex.
  • Decreased hyperthermic effect of MK-801 in selectively bred hypercholinergic rats.
  • Effects of single administration of scopolamine, physostigmine and their combination on biogenic amine levels in rat brain.
  • Paradoxical inotropic effects of clonidine and labetalol in the conscious rabbit.
  • Cardiac rate and rhythm changes with atropine and methscopolamine.
  • Automatically determined effects of lithium, scopolamine and methamphetamine on motor activity of rats.
  • Transderm scopolamine efficacy related to time of application prior to the onset of motion.
  • Repeated ketamine administration produces up-regulation of muscarinic acetylcholine receptors in the forebrain, and reduces behavioral sensitivity to scopolamine in mice.
  • Antinociceptive and toxic effects of (+)-epibatidine oxalate attributable to nicotinic agonist activity.
  • Comparative studies on the effects of the nootropic drugs adafenoxate, meclofenoxate and piracetam, and of citicholine on scopolamine-impaired memory, exploratory behavior and physical capabilities (experiments on rats and mice).
  • MK-801 and NBQX prevent electrically induced status epilepticus.
  • Characterization of 3H-N-methylscopolamine binding to intact rat thymocytes.
  • A distinctive electrophysiological signature from the Peyer's patches of rabbit intestine.
  • Neuroleptic-induced emotional defecation: effects of scopolamine and haloperidol.
  • Possible mechanism of endosulfan-induced enhancement of memory acquisition and retention in mice.
  • Pharmacological and ionic characterizations of the muscarinic receptors modulating 3Hacetylcholine release from rat cortical synaptosomes.
  • Haemodynamic effects of enflurane in patients with valvular heart disease.
  • Muscarinic antagonist enhances one-trial food-aversion learning in the mollusc Pleurobranchaea.
  • Evidence that thioridazine enhances amphetamine-induced stereotypy via anticholinergic activity.
  • Monoclonal antibody-based enzyme immunoassay for the quantitative determination of the tropane alkaloid, scopolamine.
  • Effects of pre-training administration of scopolamine on learning and retention in the cockroach, P. americana.
  • Neocortical and hippocampal electrical activity following decapitation in the rat.
  • Cholinergic influences on escape deficits produced by uncontrollable stress.
  • Estrogen and estrogen-progesterone treatments counteract the effect of scopolamine on reinforced T-maze alternation in female rats.
  • Synthesis and biological evaluation of new antimuscarinic compounds with amidine basic centers. A useful bioisosteric replacement of classical cationic heads.
  • In vivo and in vitro evidence for a common carrier mediated transport of choline and basic drugs through the blood-brain barrier.
  • Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.
  • Chronic aluminum fluoride administration. I. Behavioral observations.
  • Alteration of the rat exocrine pancreas after chronic scopolamine administration.
  • Suncus murinus as a new experimental model for motion sickness.
  • Human gastric mucosa expresses glandular M3 subtype of muscarinic receptors.
  • Effects of scopolamine on extracellular acetylcholine and choline levels and on spontaneous motor activity in freely moving rats measured by brain dialysis.
  • Status epilepticus facilitated by pilocarpine in amygdala-kindled rats.
  • Oesophageal dysfunction in familial amyloidosis with polyneuropathy.
  • Cholinergic regulation of female sexual behavior in rats demonstrated by manipulation of endogenous acetylcholine.
  • Hemodynamic changes during fentanyl--oxygen anesthesia for aortocoronary bypass operation.
  • A human embryonic lung fibroblast with a high density of muscarinic acetylcholine receptors.
  • Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats.
  • Place learning by fimbria-fornix transected rats in a modified water maze.
  • Pre- and postjunctional adreno- and muscarinic receptor functions in the isolated human corpus spongiosum urethrae.
  • Rotational behavior following cholinergic stimulation of the superior colliculus in rats.
  • Abdominal MR imaging following antegrade air introduction into the intestinal loops.
  • Evaluation of a new device for measuring oral mucosal surface friction.
  • Thermoregulatory responses following injection of 5-hydroxytryptamine into the septohippocampal complex in rats.
  • Clonidine sensitizes mice for apomorphine-induced stereotypic gnawing: antagonism by neuroleptics and cholecystokinin-like peptides.
  • Muscarinic desensitization after septal lesions in rat hippocampus: evidence for the involvement of G-proteins.
  • Substantia nigra cell death from kainic acid or folic acid injections into the pontine tegmentum.
  • Visual evoked potentials to flash and pattern reversal stimulation after administration of systemic or topical scopolamine.
  • Pharmacological characteristics of facilitation of hippocampal population spikes by cholinomimetics.
  • The effects of swallowing frequency and transdermal scopolamine on esophageal acid clearance.
  • Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells.
  • Variation of the oxime function of bispyridinium-type allosteric modulators of M2-cholinoceptors.
  • Drug effects on cognitive function in mice determined by the non-matching to sample task using a 4-arm maze.
  • Action of myenteric GABAergic neurons in the guinea pig stomach.
  • Allosteric effect of gallamine on muscarinic cholinergic receptor binding: influence of guanine nucleotides and conformational state.
  • Effects of an inhibitor of GABA-aminotransferase (gamma-vinyl-GABA) on the spatial navigation deficit induced by muscarinic blockade.
  • Premedicant drugs and gastric juice pH and volume in pediatric patients.
  • Activation of lateral geniculate neurons by locus coeruleus or dorsal noradrenergic bundle stimulation: selective blockade by the alpha 1-adrenoceptor antagonist prazosin.
  • Memory-improving action of glucose: indirect evidence for a facilitation of hippocampal acetylcholine synthesis.
  • Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.
  • Cholinergic and glutaminergic control of hippocampal RSA during behavior in rabbits.
  • Effects of human epidermal growth factor on passive avoidance and habituation learning in mice.
  • Characterization of guinea-pig cardiac muscarinic receptors by radioligand dissociation kinetics.
  • Attenuation of "acute" habituation by scopolamine in the black-tailed prairie dog (Cynomys ludovicianus).
  • Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions.
  • Scopolamine reverses haloperidol-attenuated lever-pressing for water but not haloperidol-attenuated water intake in the rat.
  • Use of promethazine to hasten adaptation to provocative motion.
  • Neural control of the heart-rate-orienting response in preweanling rats.
  • The muscarinic receptor agonist L-658,903 modulates the in vivo accumulation of inositol monophosphates in mouse brain.
  • Binding affinities of hexahydro-difenidol and hexahydro-sila-difenidol analogues at four muscarinic receptor subtypes: constitutional and stereochemical aspects.
  • Pharmacological characterization of the aminopyridazine SR 95639A, a selective M1 muscarinic agonist.
  • The function of a highly-conserved arginine residue in activation of the muscarinic M1 receptor.
  • Spectral analysis of hippocampal EEG in the freely moving rat: effects of centrally active drugs and relations to evoked potentials.
  • Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism.
  • Ameliorating effects of histidine on scopolamine-induced learning deficits using an elevated plus-maze test in mice.
  • Comparison of 3Hpirenzepine and 3Hquinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
  • Effects of arachidonic acid hydroperoxides on vascular and non-vascular smooth muscle.
  • The spontaneous activity of hippocampal neurons during the modulation of theta rhythm by cholinergic substances.
  • Effects of scopolamine hydrobromide on the development of the chick and rabbit embryo.
  • Effects of indeloxazine hydrochloride, a cerebral activator, on passive avoidance learning impaired by disruption of cholinergic transmission in rats.
  • The disordering effect of hyoscyamine drugs on phospholipid membranes.
  • Pharmacological characterization of alcohol and barbital physical dependence in mice.
  • Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
  • Molecular cloning of hyoscyamine 6 beta-hydroxylase, a 2-oxoglutarate-dependent dioxygenase, from cultured roots of Hyoscyamus niger.
  • Calcium-dependent hyperpolarizations in bullfrog sympathetic neurons.
  • GABAA and GABAB-receptor agonists evoked vagal nerve efferent transmission in the rat.
  • A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini.
  • Peripherally administered IL-1 alpha interferes with scopolamine-induced amnesia in mice.
  • An analysis of lymphocyte 3H-N-methyl-scopolamine binding in neurological patients. Evidence of altered binding in Alzheimer's disease.
  • Minaprine improves impairment of working memory induced by scopolamine and cerebral ischemia in rats.
  • Intraventricular galanin impairs delayed nonmatching-to-sample performance in rats.
  • Aniracetam reverses memory impairment in rats.
  • 5-HT1A receptor agonists improve the performance of normal and scopolamine-impaired rats in an operant delayed matching to position task.
  • Radioligand binding characteristics of the chicken cardiac muscarinic receptor.
  • Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine.
  • Central pressor effects induced by muscarinic receptor agonists: evidence for a predominant role of the M2 receptor subtype.
  • Mechanism of the galanin induced increase in acetylcholine release in vivo from striata of freely moving rats.
  • Muscarinic and nicotinic influences on masculine sexual behavior in rats: effects of oxotremorine, scopolamine, and nicotine.
  • Effects of intracranial infusions of chlordiazepoxide on spatial learning in the Morris water maze. II. Neuropharmacological specificity.
  • Reversal of androgen inhibition of estrogen-activated sexual behavior by cholinergic agents.
  • The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition.
  • Effects of intracranial injections of scopolamine on olfactory conditioning retrieval in the honeybee.
  • Effect of pH on binding of agonists and antagonists to rat heart muscarinic receptors.
  • Neurotransmitter receptors involved in post-training memory processing by the amygdala, medial septum, and hippocampus of the rat.
  • Pantoyl-gamma-aminobutyric acid facilitates cholinergic function in the central nervous system.
  • Isolated parietal cells: 3HQNB binding to putative cholinergic receptors.
  • Effects of nootropic drugs in a scopolamine-induced amnesia model in mice.
  • Selectivity of pirenzepine in the central nervous system. II. Differential effects of pirenzepine and scopolamine on performance of a representational memory task.
  • A muscarinic receptor type in human lymphocytes: a comparison of 3H-QNB binding to intact lymphocytes and lysed lymphocyte membranes.
  • Pretreatment with aldosterone or corticosterone blocks the memory-enhancing effects of nimodipine, captopril, CGP 37,849, and strychnine in mice.
  • Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
  • Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor.
  • Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze.
  • Effects of long-stimulus intervals and scopolamine administration on hippocampal kindling.
  • Muscimol-scopolamine interactions in the rat brain: a study with 2-deoxy-D-1-14Cglucose.
  • Effects of oxamniquine on chick isolated esophagus.
  • Scopolamine intoxications.
  • Tremor production by intracaudate injections of morphine.
  • Differential effects of intracerebroventricular AF64A injection, nucleus basalis of Meynert lesion, and scopolamine on place navigation and open-field behavior of rats.
  • Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication.
  • Bacterial mutagenicity investigation of epoxides: drugs, drug metabolites, steroids and pesticides.
  • Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.
  • Cholinergic mechanisms involved in head-shaking of infant rats.
  • Age-dependent modulation of in vivo cortical acetylcholine release by benzodiazepine receptor ligands.
  • Apomorphine-induced changes in striatal and pallidal neuronal activity are modified by NMDA and muscarinic receptor blockade.
  • GABA receptors are involved in the modulation of the release of 5-hydroxytryptamine from the vascularly perfused small intestine of the guinea-pig.
  • Altered pilocarpine- or chlorpromazine-induced catalepsy after long-term treatment with cholinergic drugs.
  • Role of dentate gyrus cells in retention of a radial arm maze task and sensitivity of rats to cholinergic drugs.
  • Electrical activity of the intestine in the conscious dog. Simultaneous pharmacologic investigation by chronic electrodes and electroperitoneography
  • Nicotinic-catecholaminergic interactions in rat brain: evidence for cholinergic nicotinic and muscarinic interactions with hypothalamic epinephrine.
  • Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice.
  • Central cholinergic agents. IV. Synthesis and acetylcholinesterase inhibitory activities of omega-N-ethyl-N-(phenylmethyl)amino-1-phenyl-1-alkanones and their analogues with partial conformational restriction.
  • Muscarinic receptors in isolated smooth muscle cells from gastric antrum.
  • Separation of optical isomers of scopolamine, cocaine, homatropine, and atropine.
  • Effect of buflomedil (4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxy phenyl)-1-butanone hydrochloride) on the function of striatal dopaminergic neurons.
  • Retardation of amygdala kindling by antagonism of NMD-aspartate and muscarinic cholinergic receptors: evidence for the summation of excitatory mechanisms in kindling.
  • Production of tropane alkaloids by cultured cells of a Duboisia hybrid.
  • Enteric gamma-aminobutyric acid-containing neurons and the relevance to motility of the cat colon.
  • Near-total loss of 'learning' and 'memory' as a result of combined cholinergic and serotonergic blockade in the rat.
  • Effects of ibotenic acid lesions of the basal forebrain on serial reversal learning in marmosets.
  • Acetylcholine and choline levels in rabbit fetuses exposed to anticholinergics.
  • The human astrocytoma cell line 1321 N1 contains M2-glandular type muscarinic receptors linked to phosphoinositide turnover.
  • Characterization and localization of the muscarinic cholinergic receptor in human prostatic tissue.
  • Scopolamine produces locomotor stereotypy in an open field but apomorphine does not.
  • Effects of scopolamine on locomotor activity and metabolic rate in mice.
  • Relation between long-lasting amounts of excitatory amino acid and its neuronal uptake system in cultured cerebellar granule cells under hypoglycemia.
  • Effect of vinconate on long-term potentiation in a mossy fiber-CA3 system of guinea pig hippocampal slices.
  • The novel anticonvulsant loreclezole (R 72063) does not produce diazepam-like anterograde amnesia in a passive avoidance test in rats.
  • Noradrenergic and cholinergic modulations of corticocerebellar activity modify the gain of vestibulospinal reflexes.
  • Effects of sustained low-level muscarinic agonism in rats.
  • Selective labelling of M1-receptors in autonomic ganglia with 3H-pirenzepine.
  • Postsynaptic effects of magnesium and calcium at the mouse neuromuscular junction.
  • Distance geometry of alpha-substituted 2,2-diphenylpropionate antimuscarinics.
  • Effects of concurrent manipulations of cholinergic and noradrenergic function on learning and retention in mice.
  • Lecithin organogels as matrix for the transdermal transport of drugs.
  • Effect of scopolamine on maze learning performance in humans.
  • Reversal of a mecamylamine-induced cognitive deficit with the D2 agonist, LY 171555.
  • Central cholinergic mechanisms in electrical self-stimulation and in drug-induced tremor in rats.
  • Emerging cholinergic mechanisms and ontogeny of response inhibition in the mouse.
  • Electrical versus cholinergic kindling.
  • Activation of cholinergic mechanisms in the medulla oblongata reverse intravenous opioid-induced respiratory depression.
  • Does conditioned nausea mediate drug-induced conditioned taste aversion?
  • Muscarinic cholinergic mediation of opiate and non-opiate environmentally induced analgesias.
  • Metabolic engineering of medicinal plants: transgenic Atropa belladonna with an improved alkaloid composition.
  • Detection of cholinergic mediation of behavior in 7-, 9-, and 12-day old rat pups.
  • Cholinergic influence on memory facilitation induced by angiotensin II in rats.
  • Enhancement of working memory performance in the rat by MDL 26,479, a novel compound with activity at the GABAA receptor complex.
  • Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice.
  • MK-801 impairs recognition memory in rhesus monkeys: comparison with cholinergic drugs.
  • Mode of antagonism of methoctramine, AF-DX 116 and hexahydrosiladifenidol in guinea-pig left atrium and ileum: comparison of Schild and resultant analysis.
  • Involvement of the cholinergic system in the effects of nefiracetam (DM-9384) on carbon monoxide (CO)-induced acute and delayed amnesia.
  • The muscarine antagonist methscopolamine and the NMDA antagonist AP-5 injected unilaterally into the nucleus accumbens cause mice to rotate in opposite directions.
  • The role of endotoxins in methscopolamine induced ruminal stasis in calves.
  • Long-term suppression in mice of the development of complementary memory storage sites: effect of a muscarinic antagonist.
  • Effects of hippocampal microinjections of D-amphetamine and scopolamine on active avoidance behavior in rats.
  • Negative pressure in the middle ear in children after nitrous oxide anaesthesia.
  • Differential effects of MK-801 on brain-derived neurotrophic factor mRNA levels in different regions of the rat brain.
  • Cholinergic and GABAergic modulation of medial septal area: effect on working memory.
  • Behavioral evidence for a modulating role of sigma ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia.
  • Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
  • Effects of humoral modulators and naloxone on morphine-induced changes in the spontaneous locomotor activity of the rat.
  • Central muscarinic cholinergic antagonists block wet-dog shakes produced by the TRH analog MK-771 in the rat.
  • Immunologic mimicry by a monoclonal antibody of the tricyclic anti-depressants' binding site on muscarinic acetylcholine receptors.
  • Conditioned suppression of motility: possibility for evaluation of learning and memory in mice.
  • Pupillographic analysis of morphine action in the rabbit: role to the autonomic nervous system.
  • Impairment of saccadic eye movements by scopolamine treatment.
  • Scopolamine- and morphine-induced impairments of spontaneous alternation performance in mice: reversal with glucose and with cholinergic and adrenergic agonists.
  • Antihistaminics enhance morphine-, but not amphetamine- and scopolamine-induced hyperactivity in mice.
  • The effects of morphine, morphine plus scopolamine, midazolam and promethazine on cerebrospinal fluid histamine concentration and postoperative analgesic consumption.
  • Cholinergic mediation of motor effects of ethanol in rats.
  • Assessment of the ambulation-increasing effect of ketamine by coadministration with central-acting drugs in mice.
  • A comparison of the working memory performances of young and aged mice combined with parallel measures of testing and drug-induced activations of septo-hippocampal and nbm-cortical cholinergic neurones.
  • Continuous pontine cholinergic microinfusion via mini-pump induces sustained alterations in rapid eye movement (REM) sleep.
  • Impairment of acquisition but not retention of a simple operant discrimination performance in aged Fischer 344 rats.
  • Muscarinic receptor subtype mediating vasodilation feline middle cerebral artery exhibits M3 pharmacology.
  • Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
  • Effect of 4-(o-benzylphenoxy)-N-methylbutylamine hydrochloride (MCI-2016) on the scopolamine-induced deficit of spontaneous alternation behavior in rats.
  • Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
  • Cholinergic pharmacology of mammalian hippocampal pyramidal cells.
  • Short-term disappearance of muscarinic cell surface receptors in carbachol-induced desensitization.
  • Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium.
  • Effects of a novel compound MCI-225 on impaired learning and memory in rats.
  • On the use of some multivariate statistical methods in pharmacological research.
  • Identification of multiple muscarinic binding site subtypes in cat and human cerebral vasculature.
  • The modulation by cholinergic substances of the influences of cortical input on hippocampal neurons
  • Effects of indomethacin on muscarinic inhibition of endogenous noradrenaline release from rat isolated trachea.
  • Alpha-adrenoceptors and muscarinic receptors in the isolated human prostate.
  • Central effects of muscarinic agonists and antagonists on hippocampal theta rhythm and blood pressure in the anaesthetised rat.
  • Development of the muscarinic receptor in rabbit gastric smooth muscle.
  • Synthesis and amnesia-reversal activity of a series of 7- and 5-membered 3-acylamino lactams.
  • Effects of central muscarinic blockade on passive avoidance: anterograde amnesia, state dependency, or both?
  • Characterization of muscarinic receptor subtypes in canine left ventricular membranes.
  • Characterization of muscarinic receptors of bovine coronary artery by functional and radioligand binding studies.
  • Characterization of muscarinic acetylcholine receptors on the rat pancreatic gastrin-producing cell line B6 RIN.
  • Scopolamine-induced muscarinic supersensitivity in normal man: changes in sleep.
  • Some effects of CNS cholinergic neurons on memory.
  • Plasticity of brain muscarinic receptors in aging rats: the adaptative response to scopolamine and ethanol treatment.
  • Analysis of cardiac muscarinic receptors recognized selectively by nonquaternary but not by quaternary ligands.
  • Characterization of muscarinic receptors in salivary and lacrimal glands of the rat.
  • Characterization of muscarinic receptors in human submandibular salivary glands.
  • Characterization of muscarinic cholinergic receptor binding in the vas deferens, bladder, prostate and penis of the rabbit.
  • Characterization of muscarinic receptor subtypes in pig airways: radioligand binding and northern blotting studies.
  • Lack of coupling of muscarinic receptors to phosphoinositide metabolism and adenylyl cyclase in human lymphocytes and polymorphonuclear leukocytes: studies in healthy subjects and allergic asthmatic patients.
  • Characterization of muscarinic acetylcholine receptors in the isolated gastric chief cells from guinea pig
  • Chemical kindling by muscarinic amygdaloid stimulation in the rat.
  • Ontogeny of M1 and M2 muscarinic binding sites in the striatum of the cat: relationships to one another and to striatal compartmentalization.
  • Opposite effects of cholinergic agents and benzodiazepine receptor ligands in a passive avoidance task in rats.
  • Routes of delivery of muscarinic acetylcholine receptors to the plasma membrane in NG108-15 cells.
  • Lack of alterations in muscarinic receptor subtypes and phosphoinositide hydrolysis upon acute DFP treatment.
  • The effects of several muscarinic antagonists on pre- and postsynaptic receptors in the isolated rabbit heart.
  • SDZ ENS 163, a selective muscarinic M1 receptor agonist, facilitates the induction of long-term potentiation in rat hippocampal slices.
  • Physiological effects of muscarinic vs nicotinic ACh antagonists upon ganglion cell activity in the frog retina.
  • Short-term regulation of muscarinic acetylcholine receptor binding in cultured nerve cells.
  • Synaptic ion currents in muscle fibers of Drosophila melanogaster
  • Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors.
  • Action of PMA (phorbol myristate acetate), scopolamine, propranolol, and oxotremorine on memorization of an active or passive avoidance test
  • Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
  • Increased muscarinic cholinergic receptor density on CD4+ lymphocytes in progressive multiple sclerosis.
  • Effects of N-allylnormetazocine (SKF 10,047), phencyclidine, and other psychomotor stimulants in the rat following 6-hydroxydopamine lesion of the ventral tegmental area.
  • Facilitation of amphetamine-induced rotation by muscarinic antagonists is correlated with M2 receptor affinity.
  • Effects of nicotine on neocortical electrical activity in rats.
  • The topography of amphetamine and scopolamine-induced hyperactivity: toward an activity print.
  • Behavioral effects of neonatal treatment with clomipramine, scopolamine, and idazoxan in male rats.
  • Discrimination by N-ethylmaleimide between the chronotropic and inotropic response to muscarinic receptor stimulation in rat atrium.
  • Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes.
  • Different effects of neuropeptide Y on electrically induced contractions in the longitudinal and circular smooth muscle layers of the female rabbit urethra.
  • Disordered cholinergic neurotransmission and dysautoregulation after acute cerebral infarction.
  • The influences of neurotransmitters on the traumatic unconsciousness, immediate convulsion and mortality in the experimental mice model
  • Role of emotions in cholinergic mechanisms of formation and reproduction of a bilateral conditioned avoidance reflex
  • The effects of exifone, a new agent for senile memory disorder, on two models of memory in the mouse.
  • Dual muscarinic and nicotinic action on a motor program in Drosophila.
  • Effects of concomitant nicotinic and muscarinic blockade on spatial memory disturbance in rats are purely additive: evidence from the Morris water task.
  • The role of calcium in amrinone action on intestinal smooth muscle.
  • D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
  • Adrenergic and non-adrenergic contraction of isolated urethral muscle from rabbit and man.
  • Facilitatory but nonessential role of the muscarinic cholinergic system in the generation of long-term potentiation of population spikes in the dentate gyrus in vivo.
  • A novel series of non-quaternary oxadiazoles acting as full agonists at muscarinic receptors.
  • Avoidance facilitation by nootropics.
  • Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro4.5decane derivatives, YM796 and YM954.
  • Role of the striatal cholinergic system in the regulation of learned manipulation in rats.
  • Cholinergic and noradrenergic modulation of the slow (approximately 0.3 Hz) oscillation in neocortical cells.
  • Effects of WEB 1881 FU, a novel nootropic, on cholinergic and adrenergic receptors in the rat brain: action on M1-muscarinic receptors.
  • Tetrahydroprotoberberine--a new chemical type of antagonist of dopamine receptors.
  • Locomotor activity and the nucleus accumbens
  • Prevention of guanine nucleotide-induced reductions in muscarinic agonist binding to rabbit ileal submucosal membranes by lidamidine and tetracaine.
  • Effects of general anaesthetics on the pH of gastric contents in man during surgery: a survey of halothane, fluoroxene and cyclopropane anesthesia.
  • D2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons.
  • Effects of citicholine and of the combination citicholine + piracetam on the memory (experiments on mice).
  • Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites.
  • Characteristics of effects of repeated scopolamine administration on ambulatory activity in mice and methamphetamine sensitivity in the scopolamine-experienced mice: comparison among 6 strains.
  • A long-lasting cholinesterase inhibitor affecting neural and behavioral processes.
  • Analysis of the activation of dopamine metabolism by a serotonin uptake inhibitor.
  • Molecular weight estimates of insect cholinergic receptors by radiation inactivation.
  • Environmentally induced analgesia: age-related decline in a neurally mediated, nonopioid system.
  • Scopolamine impairs recall of one-trial stimulus-reward association in monkeys.
  • Scopolamine blocks olfaction-induced fast waves but not olfactory evoked potentials in the dentate gyrus.
  • The effects of scopolamine on event-related potentials in a continuous recognition memory task.
  • Effects of ginsenoside Rb1 on central cholinergic metabolism.
  • Effects of benzodiazepines on passive avoidance response and latent learning in mice: relationship to benzodiazepine receptors and the cholinergic neuronal system.
  • The effects of apomorphine on leverpress shock escape learning in rats.
  • The effects of scopolamine on extinction and spontaneous recovery.
  • Adrenoceptors and cholinoceptors controlling noradrenaline release from adrenergic nerves in the urethra of rabbit and man.
  • Spinal mechanisms of the analgesic action of electroconvulsive shock.
  • Antagonism of endogenous opioids modulates memory processing.
  • Electrophysiological analysis of responses to intrinsic nerves in circular muscle of opossum esophageal muscle.
  • The antiamnesic properties of antidepressants
  • A comparison of the effects of diazepam and scopolamine in two positively reinforced learning tasks.
  • A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.
  • A comparison of the effects of scopolamine and diazepam on acquisition and retention of inhibitory avoidance in mice.
  • Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes.
  • Development and application of a radioreceptor assay for scopolamine.
  • Selective cytotoxic lesions of the hippocampal formation and DRL performance in rats.
  • Muscarin-sensitive cholinoreactive systems in the respiratory center
  • Biochemical characteristics of muscarinic cholinoreceptors in swine tracheal smooth muscle.
  • Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade.
  • An alkylating derivative of oxotremorine interacts irreversibly with the muscarinic receptor.
  • Amphetamine sensitization and amygdala kindling: pharmacological evaluation of catecholaminergic and cholinergic mechanisms.
  • Solid-state stereochemistry of (-)-scopolamine hydrobromide sesquihydrate, a new polymorph of the anticholinergic drug.
  • Interactive effects of D1 and D2 agonists with scopolamine on radial-arm maze performance.
  • Selective potentiations in opioid analgesia following scopolamine pretreatment.
  • Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats.
  • Delirium after elective orthopedic surgery: risk factors and natural history.
  • Involvement of nitric oxide-formation in the action of losartan (DuP 753): effects in an inhibitory avoidance model.
  • Hippocampal muscarinic cholinergic mediation of spontaneous alternation and fear in the developing rat.
  • Mode of regulation of the ACh-sensitive K-channel by the muscarinic receptor in rabbit atrial cells.
  • Effects of oxiracetam-scopolamine combinations on shuttle-box avoidance acquisition in mice.
  • Visual discrimination and P300 are affected in parallel by cholinergic agents in the behaving monkey.
  • Effects of systemic pancreastatin on memory retention.
  • Muscarinic receptors in pancreatic islets of the rat. Demonstration and dependence on long-term glucose environment.
  • Muscarinic modulation of a pattern-generating network: control of neuronal properties.